Cargando…
Combined use of coenzyme Q10 and citicoline: A new possibility for patients with glaucoma
Glaucoma is the leading cause of irreversible blindness worldwide. Several risk factors have been involved in the pathogenesis of the disease. By now, the main treatable risk factor is elevated intraocular pressure. Nevertheless, some patients, whose intraocular pressure is considered in the target...
Autores principales: | Martucci, Alessio, Mancino, Raffaele, Cesareo, Massimo, Pinazo-Duran, Maria Dolores, Nucci, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797721/ https://www.ncbi.nlm.nih.gov/pubmed/36590976 http://dx.doi.org/10.3389/fmed.2022.1020993 |
Ejemplares similares
-
Evidence on neuroprotective properties of coenzyme Q10 in the treatment of glaucoma
por: Martucci, Alessio, et al.
Publicado: (2019) -
Editorial: New perspectives in glaucoma pathophysiology, diagnosis, and treatment
por: Martucci, Alessio, et al.
Publicado: (2023) -
The Role of Citicoline and Coenzyme Q10 in Retinal Pathology
por: García-López, Claudia, et al.
Publicado: (2023) -
Is there a relationship between dopamine and rhegmatogenous retinal detachment?
por: Martucci, Alessio, et al.
Publicado: (2019) -
Macular ganglion cells alteration in a patient with left homonymous hemianopia subsequent to surgical excision of an arteriovenous malformation
por: Martucci, Alessio, et al.
Publicado: (2018)